Latest News
Medidata Partners with CTI for Remote Source Review of Clinical Trials in Response to COVID-19
8 July 2020 - - US-based contract research organization CTI Clinical Trial and Consulting Services will use US-based clinical trial solutions provider Medidata's Remote Source Review to power remote monitoring and document review for multiple gl...
LYNPARZA Approved in the EU for Germline BRCA-mutated Metastatic Pancreatic Cancer
8 July 2020 - - LYNPARZA has been approved in the European Union as a monotherapy for the maintenance treatment of adult patients with germline BRCA1/2 mutations who have metastatic adenocarcinoma of the pancreas and have not progressed after a ...
Gilead Sciences Presents Survey Findings on PrEP Access and Utilization in the US During COVID-19 Shelter-in-Place Orders
8 July 2020 - - Data presented at the 23rd International AIDS Conference (AIDS 2020: Virtual) evaluated the impact of COVID-19 shelter-in-place orders (SIPOs) and PrEP utilisation on HIV prevention strategies and associated risk behaviours, US-b...
FDA Approves Talaris Therapeutics' IND for Its Allogeneic Cell Therapy FCR001 to Be Evaluated in Patients with a Severe form of Scleroderma
8 July 2020 - - The US Food and Drug Administration has approved US-based biotechnology company Talaris Therapeutics, Inc's Investigational New Drug application for the evaluation of Talaris' novel cell therapy FCR001 in the treatment of di...
Alnylam Pharmaceuticals and Taiba Group Partner to Commercialize RNAi Therapeutics in the Gulf States
8 July 2020 - - Swiss RNAi therapeutics company Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) and UAE-based rare disease company taiba Middle East have formed a Distribution Agreement for both ONPATTRO and GIVLAARI, the first-ever commercial...